Chronicity Counts: The Impact of <i>Pseudomonas aeruginosa</i>, <i>Staphylococcus aureus</i>, and Coinfection in Cystic Fibrosis-Reference-Cited by-同舟云学术

Chronicity Counts: The Impact of Pseudomonas aeruginosa, Staphylococcus aureus, and Coinfection in Cystic Fibrosis

Published:2024-07-15 Issue:2 Volume:210 Page:240-242
ISSN:1073-449X
Container-title:American Journal of Respiratory and Critical Care Medicine
language:en
Short-container-title:Am J Respir Crit Care Med

Author:

Mossop Micaela¹²^ORCID,Ish-Horowicz Jonathan¹^ORCID,Hughes Dominic¹³^ORCID,Dobra Rebecca²^ORCID,Cunanan Alessandra G.¹²,Rosenthal Mark²,Carr Siobhán B.¹²,Ramadan Newara²^ORCID,Nolan Laura M.¹⁴^ORCID,Davies Jane C.¹²

Affiliation:

1. National Heart and Lung Institute, Imperial College London, London, United Kingdom;

2. Royal Brompton & Harefield Hospitals, part of Guys and St Thomas’ Trust, London, United Kingdom;

3. King’s College Hospital National Health Service Foundation Trust, London, United Kingdom; and

4. Quadram Institute Bioscience, Norwich, United Kingdom

Funder

Cystic Fibrosis Trust

Imperial College London

NIHR Imperial Biomedical Research Centre

Biotechnology and Biological Sciences Research Council

Publisher

American Thoracic Society

Link

https://www.atsjournals.org/doi/pdf/10.1164/rccm.202312-2326LE

Reference10 articles.

1. Pseudomonas aeruginosa in the Cystic Fibrosis Airway: Does It Deserve Its Reputation as a Predatory “Bully”?

2. Mixed Populations and Co-Infection: Pseudomonas aeruginosa and Staphylococcus aureus

3. Impact of Pseudomonas and Staphylococcus Infection on Inflammation and Clinical Status in Young Children with Cystic Fibrosis

4. Staphylococcus aureus and Pseudomonas aeruginosa co-infection is associated with cystic fibrosis-related diabetes and poor clinical outcomes